Antibody tests for identification of current and past infection with SARS‐CoV‐2
T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Humoral responses and serological assays in SARS-CoV-2 infections
Y Galipeau, M Greig, G Liu, M Driedger… - Frontiers in …, 2020 - frontiersin.org
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2 …
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2 …
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
The effectiveness of COVID-19 vaccination in preventing new severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections in the general community is still unclear …
syndrome coronavirus 2 (SARS-CoV-2) infections in the general community is still unclear …
[HTML][HTML] Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: A systematic analysis
Background The infection-fatality ratio (IFR) is a metric that quantifies the likelihood of an
individual dying once infected with a pathogen. Understanding the determinants of IFR …
individual dying once infected with a pathogen. Understanding the determinants of IFR …
Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O'Donnell, NE Stoesser… - … England Journal of …, 2021 - Mass Medical Soc
Background The relationship between the presence of antibodies to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …
[PDF][PDF] Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
KL Bajema, RE Wiegand, K Cuffe, SV Patel… - JAMA internal …, 2021 - jamanetwork.com
Importance Case-based surveillance of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection likely underestimates the true prevalence of infections. Large-scale …
(SARS-CoV-2) infection likely underestimates the true prevalence of infections. Large-scale …
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby… - Medrxiv, 2021 - medrxiv.org
Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV …
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV …
Association of SARS-CoV-2 seropositive antibody test with risk of future infection
RA Harvey, JA Rassen, CA Kabelac… - JAMA internal …, 2021 - jamanetwork.com
Importance Understanding the effect of serum antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for …
syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for …